Invention Grant
- Patent Title: Treating critically ill patients with intravenous ibuprofen
-
Application No.: US15484349Application Date: 2017-04-11
-
Publication No.: US09931311B2Publication Date: 2018-04-03
- Inventor: Leo Pavliv , Amy Dix Rock
- Applicant: Cumberland Pharmaceuticals Inc.
- Applicant Address: US TN Nashville
- Assignee: Cumberland Pharmaceuticals Inc.
- Current Assignee: Cumberland Pharmaceuticals Inc.
- Current Assignee Address: US TN Nashville
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A01N37/10
- IPC: A01N37/10 ; A61K31/192 ; A61K31/197 ; A61K9/00 ; A61K45/06 ; A61K9/08 ; A61K47/18

Abstract:
Methods of treating at least one condition chosen from pain, inflammation, and fever in a critically ill patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen using a first dosage regimen, wherein the first dosage regimen produces a first pharmacokinetic profile in critically ill patients that is about equivalent to a second pharmacokinetic profile produced by administration of the intravenous pharmaceutical composition using a second dosage regimen of ibuprofen to non-critically ill patients, wherein the at least one condition of the critically ill patient is thereby treated.
Public/Granted literature
- US20170216232A1 TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN Public/Granted day:2017-08-03
Information query